Low Levels of Vitamin B12 linked to Hypothyroidism

Some vitamins play a role in moderating thyroid function, including vitamins A, B, D, and E.2 In the case of B complex vitamins, B12 is indispensable to several biochemical processes and plays a central role in hematopoiesis.

The pooled frequencies, mean differences (MD), and 95% confidence intervals (CI) of vitamin B12 levels in adult patients with thyroid disorders and healthy controls was evaluated using a meta-analysis of random-effects model. A systematic search was conducted in Scopus, Web of Science, Embase, and PubMed.

Eligible studies evaluated the frequency of B12 deficiency in patients with thyroid disorders, differences in the B12 levels between patients with thyroid disorders and healthy controls, and the frequency of anti-parietal cell antibodies (APCA) in patients with thyroid disorders.

In total, 64 studies (n=28,597), published between 1967 and 2022, were identified. Forty studies analyzed B12 abnormalities in patients with hypothyroidism, 17 evaluated B12 levels in patients with hyperthyroidism, 21 focused on B12 deficiencies in patients with AITD, and 10 evaluated B12 deficiencies in patients with SH. Patients with hypothyroidism had lower levels of vitamin B12 when compared with healthy participants (MD: -60.67 pg/mL; 95% CI: -107.31 to -14.03 pg/mL; P = 0.01).

No significant differences in B12 levels were noted between healthy controls and patients with AITD (MD: −19.28 pg/mL; 95% CI: −50.04 to 11.48 pg/mL; P = 0.22), SH (MD: −2.71 pg/mL; 95% CI: −23.12 to 17.7 pg/mL; P = 0.79), or hyperthyroidism (MD: −7.71 pg/mL; 95% CI: −62.96 to 47.55 pg/mL; P = 0.78).

The incidence of a vitamin B12 deficiency was 27% in the hypothyroidism group, 17% for patients with SH, 18% for those with AITD, and 6% for patients with a hyperthyroidism diagnosis. The co-occurrence of APCA and vitamin B12 deficiency in patients with thyroid disorders did not surpass 30% in any of the included studies.

According to investigators, the high statistical heterogeneity could only be reduced via a sensitivity analysis in some cases. Additionally, most studies included in the analysis were conducted in Asia, which may have limited the findings. Therefore, differences in B12 levels among patients of different ethnicities should be evaluated and compared to determine generalizability. The vitamin B12 levels were not adjusted for sociodemographic variables or comorbidities, which could have allowed for a cut-off consensus. Investigators emphasized the need for future research to address these concerns.

The findings are particularly useful in clinical settings as they emphasize the necessity of in-depth evaluations of vitamin B12 levels in patients with thyroid disorders,” investigators concluded. “Nearly 1 in 4 patients with either SH or hypothyroidism suffers from B12 deficiency. Although it is tempting to suggest routine vitamin B12 assessment in patients with thyroid disorders, more studies are needed to support this practice,

References:

Benites-Zapata VA, Ignacio-Cconchoy FL, Ulloque-Badaracco JR, et al. Vitamin B12 levels in thyroid disorders: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023;14:1070592. Published 2023 Feb 22. doi:10.3389/fendo.2023.1070592

Triggiani V, Tafaro E, Giagulli V, Sabba C, Resta F, Licchelli B, et al. Role of iodine, selenium and other micronutrients in thyroid function and disorders. Endocr Metab Immune Disord Drug Targets (2009) 9:277–94. doi: 10.2174/187153009789044392